A new all-oral, six-month treatment regimen is safer and more effective at treating multidrug-resistant tuberculosis
A new all-oral, six-month treatment regimen is safer and more effective at treating multidrug-resistant tuberculosis (MDR-TB) than the current options, according to results of a Doctors Without Borders/Médecins Sans Frontières (MSF) study published in the New England Journal of Medicine today. These findings come from MSF’s TB PRACTECAL, the first-ever multi-country, randomized, controlled clinical trial to…